Jung Yongtae | School of Biomedical Sciences
Introduction
I joined as a faculty at the University of Dankook in 2003 after completing Ph.D. degree at the University of Korea in Microbiology, and following postdoctoral training in the National Institute of Allergy and Infectious Diseases (NIAID) of National Institutes of Health (NIH) in Bethesda, MD, USA. I teach undergraduate and graduate courses in cell biology, virology, cancer biology and immunology. My research has involved several areas of microbiology and virology. I am working on a number of retrovirus-related projects including (1) the mechanism of cellular restriction factor against retroviral infection, (2) analysis of syncytium formation mechanism induced by ecotropic murine retrovirus, (3) Evaluation of the potential risk of porcine endogenous retrovirus(PERV) infection in vivo after xenotransplantation.
Teaching Philosophy
The Roman philosopher said “While we teach, we learn”. I want to teach the students how to find information from variety of sources and how to organize their knowledge. To support students act as tutors, it is important to help the students develop their social and interaction skills.
Educational Background
- [1989] bachelor's degree Dept. of Biology, Korea University
- [1993] master's degree Dept. of Microbiology, Korea University
- [1997] doctor's degree Dept. of Microbiology, Korea University
Career
- Korea University (1991-09-01)
- Korea University (1992-03-02)
- Korea University (1997-03-02)
- Catholic University, Medical College (1993-03-02)
- NINDS,NIH,USA (1997-09-08)
- NIAID,NIH,USA (1998-05-01)
Research
(1)The mechanism of cellular restriction factor against retroviral infection.
(2)Analysis of syncytium formation mechanism induced by ecotropic murine retrovirus.
(3) Evaluation of the potential risk of porcine endogenous retrovirus(PERV) infection in vivo after xenotransplantation.
(4) Development of a novel replication competent retroviral vectors.
Consulting
1.Evaluation of the potential risk of porcine endogenous retrovirus(PERV) infection in vivo after xenotransplantation
2. Development of a novel replication competent retroviral vectors